(Q38739123)

English

4-Chlorbenzoyl Berbamine, a Novel Derivative of the Natural Product Berbamine, Potently Inhibits the Growth of Human Myeloma Cells by Modulating the NF-κB and JNK Signalling Pathways

scientific article published on 21 October 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

4-Chlorbenzoyl Berbamine, a Novel Derivative of the Natural Product Berbamine, Potently Inhibits the Growth of Human Myeloma Cells by Modulating the NF-κB and JNK Signalling Pathways (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

0 references

natural product

1 reference

based on heuristic

inferred from title

author name string

Yun Liang

1

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xin He

2

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xian Li

3

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xuzhao Zhang

4

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xiaohong Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Lei Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xi Qiu

7

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Xiaoying Zhao

8

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Rongzhen Xu

9

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Cancer Investigation

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

496-505

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Treatment of multiple myeloma: a comprehensive review

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Molecular mechanisms of novel therapeutic approaches for multiple myeloma

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Advances in biology of multiple myeloma: clinical applications

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML.

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Molecular understanding and modern application of traditional medicines: triumphs and trials.

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Anti-inflammatory and immunosuppressive properties of the bis-benzylisoquinolines: in vitro comparisons of tetrandrine and berbamine.

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Berbamine: a novel inhibitor of bcr/abl fusion gene with potent anti-leukemia activity

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4''-carbamate, 11,12-cyclic carbonate-4''-carbamate and 11,4''-di-O-arylcarbamoyl analogs of azithromycin

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Berbamine, a novel nuclear factor kappaB inhibitor, inhibits growth and induces apoptosis in human myeloma cells

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Berbamine enhances the antineoplastic activity of gemcitabine in pancreatic cancer cells by activating transforming growth factor-β/Smad signaling

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Targeted cancer therapy with novel high drug-loading nanocrystals

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Novel synthetic derivatives of the natural product berbamine inhibit Jak2/Stat3 signaling and induce apoptosis of human melanoma cells

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

A novel synthetic derivative of the natural product berbamine inhibits cell viability and induces apoptosis of human osteosarcoma cells, associated with activation of JNK/AP-1 signaling

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced upon apoptosis

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

To be, or not to be: NF-kappaB is the answer--role of Rel/NF-kappaB in the regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Microenvironment and multiple myeloma spread

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Lenalidomide and thalidomide: an evolving paradigm for the management of multiple myeloma

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

NF-κB, an active player in human cancers

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

The NF-kappaB regulatory network

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

The transcriptional specificity of NF-κB dimers is coded within the κB DNA response elements

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Inhibition of NF-kappa B stabilizes gadd45 alpha mRNA

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Linking JNK signaling to NF-kappaB: a key to survival

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

A20 inhibits NF-kappa B activation downstream of multiple Map3 kinases and interacts with the I kappa B signalosome

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

The MAPK pathway across different malignancies: a new perspective

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells

1 reference

https://api.crossref.org/works/10.1080%2F07357907.2016.1235709

21 January 2018

Identifiers

10.1080/07357907.2016.1235709

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38739123&oldid=1781676526"